Regulation of the NF-κB-mediated transcription of inflammatory genes

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Bhatt, Dev ^a   Ghosh, Sankar ^a  

^a Department of Microbiology and Immunology College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

Chromatin; Gene expression; NF kappaB; Signaling; Transcription; Transcription factor

Indexed keywords

BETA INTERFERON; DNA DIRECTED DNA POLYMERASE ALPHA; E1A ASSOCIATED P300 PROTEIN; GENERAL TRANSCRIPTION FACTOR; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; MEDIATOR COMPLEX; NUCLEAR RECEPTOR COREPRESSOR; PROTEASOME; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR IIH;

CELL DIFFERENTIATION; CHROMATIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HEMOSTASIS; HISTONE METHYLATION; HUMAN; IMMUNOLOGICAL MEMORY; INFLAMMATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION ELONGATION; TRANSCRIPTION REGULATION;

EID: 84895521826     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00071     Document Type: Review

References (79)

1. Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev (2006) 210:171-86. doi:10.1111/j.0105-2896.2006.00375.x.
2. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell (2008) 132:344-62. doi:10.1016/j.cell.2008.01.020.
3. Carey M, Peterson CL, Smale ST. Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and Techniques. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press (2008).
4. Venters BJ, Pugh BF. How eukaryotic genes are transcribed. Crit Rev Biochem Mol Biol (2009) 44:117-41. doi:10.1080/10409230902858785.
5. Malik S, Roeder RG. The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet (2010) 11:761-72. doi:10.1038/nrg2901.
6. Kawaji H, Frith MC, Katayama S, Sandelin A, Kai C, Kawai J, et al. Dynamic usage of transcription start sites within core promoters. Genome Biol (2006) 7:R118. doi:10.1186/gb-2006-7-12-r118.
7. Juven-Gershon T, Hsu J-Y, Theisen JW, Kadonaga JT. The RNA polymerase II core promoter-the gateway to transcription. Curr Opin Cell Biol (2008) 20:253-9. doi:10.1016/j.ceb.2008.03.003.
8. Smale ST, Kadonaga JT. The RNA polymerase II core promoter. Annu Rev Biochem (2003) 72:449-79. doi:10.1146/annurev.biochem.72.121801.161520.
9. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell (2007) 128:707-19. doi:10.1016/j.cell.2007.01.015.
10. Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature (1997) 389:251-60. doi:10.1038/38444.
11. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res (2011) 21:381-95. doi:10.1038/cr.2011.22.
12. Yun M, Wu J, Workman JL, Li B. Readers of histone modifications. Cell Res (2011) 21:564-78. doi:10.1038/cr.2011.42.
13. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell (2010) 38:576-89. doi:10.1016/j.molcel.2010.05.004.
14. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity (2010) 32:317-28. doi:10.1016/j.immuni.2010.02.008.
15. Thanos D, Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell (1995) 83:1091-100. doi:10.1016/0092-8674(95)90136-1.
16. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell (2000) 103:667-78. doi:10.1016/S0092-8674(00)00169-0.
17. Ford E, Thanos D. The transcriptional code of human IFN-beta gene expression. Biochim Biophys Acta (2010) 1799:328-36. doi:10.1016/j.bbagrm.2010.01.010.
18. Plevy S, Gemberling JH, Hsu S, Donner AJ, Smale ST. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol (1997) 17:4572-88.
19. Zhu C, Gagnidze K, Gemberling JH, Plevy S. Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach. J Biol Chem (2001) 276:18519-28. doi:10.1074/jbc.M100440200.
20. Zhu C, Rao K, Xiong H, Gagnidze K, Li F, Horvath C, et al. Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J Biol Chem (2003) 278:39372-82. doi:10.1074/jbc.M306441200.
21. Murphy T, Cleveland M, Kulesza P, Magram J, Murphy K. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol Cell Biol (1995) 15:5258-67.
22. Weinmann AS, Plevy S, Smale ST. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity (1999) 11:665-75. doi:10.1016/S1074-7613(00)80141-7.
23. Weinmann AS, Mitchell DM, Sanjabi S, Bradley MN, Hoffmann A, Liou HC, et al. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat Immunol (2001) 2:51-7. doi:10.1038/83168.
24. Zhou L, Nazarian AA, Xu J, Tantin D, Corcoran LM, Smale ST. An inducible enhancer required for Il12b promoter activity in an insulated chromatin environment. Mol Cell Biol (2007) 27:2698-712. doi:10.1128/MCB.00788-06.
25. Saccani S, Pantano S, Natoli G. Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med (2001) 193:1351-9. doi:10.1084/jem.193.12.1351.
26. Müller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC. Structure of the NF-kappa B p50 homodimer bound to DNA. Nature (1995) 373:311-7. doi:10.1038/373311a0.
27. Chen FE, Huang D-B, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature (1998) 391:410-3. doi:10.1038/34356.
28. Ghosh G, Wang VY-F, Huang D-B, Fusco A. NF-κB regulation: lessons from structures. Immunol Rev (2012) 246:36-58. doi:10.1111/j.1600-065X.2012.01097.x.
29. Steger DJ, Workman JL. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J (1997) 16:2463-72. doi:10.1093/emboj/16.9.2463.
30. Angelov D, Lenouvel F, Hans F, Müller CW, Bouvet P, Bednar J, et al. The histone octamer is invisible when NF-kappaB binds to the nucleosome. J Biol Chem (2004) 279:42374-82. doi:10.1074/jbc.M407235200.
31. Lone IN, Shukla MS, Charles Richard JL, Peshev ZY, Dimitrov S, Angelov D. Binding of NF-κB to nucleosomes: effect of translational positioning, nucleosome remodeling and linker histone H1. PLoS Genet (2013) 9:e1003830. doi:10.1371/journal.pgen.1003830.
32. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell (2002) 9:625-36. doi:10.1016/S1097-2765(02)00477-X.
33. Saccani S, Pantano S, Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell (2003) 11:1563-74. doi:10.1016/S1097-2765(03)00227-2.
34. Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN, et al. Selective and antagonistic functions of SWI/SNF and Mi-2 beta nucleosome remodeling complexes during an inflammatory response. Genes Dev (2006) 20:282-96. doi:10.1101/gad.1383206.
35. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell (2009) 138:114-28. doi:10.1016/j.cell.2009.04.020.
36. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 138:129-45. doi:10.1016/j.cell.2009.05.047.
37. Deaton AM, Bird AP. CpG islands and the regulation of transcription. Genes Dev (2011) 25:1010-22. doi:10.1101/gad.2037511.
38. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature (2010) 464:1082-6. doi:10.1038/nature08924.
39. Lee J-H, Skalnik DG. CpG-binding protein (CXXC finger protein 1) is a component of the mammalian Set1 histone H3-Lys4 methyltransferase complex, the analogue of the yeast Set1/COMPASS complex. J Biol Chem (2005) 280:41725-31. doi:10.1074/jbc.M508312200.
40. Fenouil R, Cauchy P, Koch F, Descostes N, Cabeza JZ, Innocenti C, et al. CpG islands and GC content dictate nucleosome depletion in a transcription-independent manner at mammalian promoters. Genome Res (2012) 22:2399-408. doi:10.1101/gr.138776.112.
41. O'Shea JM, Perkins ND. Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans (2008) 36:603-8. doi:10.1042/BST0360603.
42. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J (2003) 22:1313-24. doi:10.1093/emboj/cdg139.
43. Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G. Cyclic AMP: a selective modulator of NF-κB action. Cell Mol Life Sci (2011) 68:3823-41. doi:10.1007/s00018-011-0757-8.
44. Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65. Cell Death Differ (2010) 17:689-98. doi:10.1038/cdd.2009.174.
45. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell (1997) 89:413-24. doi:10.1016/S0092-8674(00)80222-6.
46. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell (1998) 1:661-71. doi:10.1016/S1097-2765(00)80066-0.
47. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S. Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev (2008) 22:1159-73. doi:10.1101/gad.1657408.
48. Mukherjee SP, Behar M, Birnbaum HA, Hoffmann A, Wright PE, Ghosh G. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription. PLoS Biol (2013) 11:e1001647. doi:10.1371/journal.pbio.1001647.
49. Yang X-D, Huang B, Li M, Lamb A, Kelleher NL, Chen L-F. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J (2009) 28:1055-66. doi:10.1038/emboj.2009.55.
50. Yang X-D, Tajkhorshid E, Chen L-F. Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB. Mol Cell Biol (2010) 30:2170-80. doi:10.1128/MCB.01343-09.
51. Kim J-W, Jang S-M, Kim C-H, An J-H, Kang E-J, Choi K-H. New molecular bridge between RelA/p65 and NF-κB target genes via histone acetyltransferase TIP60 cofactor. J Biol Chem (2012) 287:7780-91. doi:10.1074/jbc.M111.278465.
52. Huang B, Yang X-D, Lamb A, Chen L-F. Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal (2010) 22:1282-90. doi:10.1016/j.cellsig.2010.03.017.
53. Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene (2006) 25:6717-30. doi:10.1038/sj.onc.1209937.
54. van Essen D, Zhu Y, Saccani S. A feed-forward circuit controlling inducible NF-κB target gene activation by promoter histone demethylation. Mol Cell (2010) 39:750-60. doi:10.1016/j.molcel.2010.08.010.
55. Saccani S, Natoli G. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev (2002) 16:2219-24. doi:10.1101/gad.232502.
56. De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J (2009) 28:3341-52. doi:10.1038/emboj.2009.271.
57. Kruidenier L, Chung C, Cheng Z, Liddle J, Che K, Joberty G, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature (2012) 488:404-8. doi:10.1038/nature11262.
58. Ghisletti S, Huang W, Jepsen K, Benner C, Hardiman G, Rosenfeld MG, et al. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev (2009) 23:681-93. doi:10.1101/gad.1773109.
59. Huang W, Ghisletti S, Perissi V, Rosenfeld MG, Glass CK. Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. Mol Cell (2009) 35:48-57. doi:10.1016/j.molcel.2009.05.023.
60. Stender JDD, Pascual G, Liu W, Kaikkonen MU, Do K, Spann NJJ, et al. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol Cell (2012) 48:28-38. doi:10.1016/j.molcel.2012.07.020.
61. Li P, Spann NJ, Kaikkonen MU, Lu M, Oh DY, Fox JN, et al. NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell (2013) 155:200-14. doi:10.1016/j.cell.2013.08.054.
62. Chen X, Barozzi I, Termanini A, Prosperini E, Recchiuti A, Dalli J, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci U S A (2012) 109:E2865-74. doi:10.1073/pnas.1121131109.
63. Saunders A, Core LJ, Lis JT. Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol (2006) 7:557-67. doi:10.1038/nrm1981.
64. Fuda NJ, Ardehali MB, Lis JT. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature (2009) 461:186-92. doi:10.1038/nature08449.
65. Brès V, Yoh SM, Jones KA. The multi-tasking P-TEFb complex. Curr Opin Cell Biol (2008) 20:334-40. doi:10.1016/j.ceb.2008.04.008.
66. Nechaev S, Adelman K. Pol II waiting in the starting gates: regulating the transition from transcription initiation into productive elongation. Biochim Biophys Acta (2011) 1809:34-45. doi:10.1016/j.bbagrm.2010.11.001.
67. Ainbinder E, Amir-Zilberstein L, Yamaguchi Y, Handa H, Dikstein R. Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-kappaB. Mol Cell Biol (2004) 24:2444-54. doi:10.1128/MCB.24.6.2444-2454.2004.
68. Adelman K, Kennedy MA, Nechaev S, Gilchrist DA, Muse GW, Chinenov Y, et al. Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Proc Natl Acad Sci U S A (2009) 106:18207-12. doi:10.1073/pnas.0910177106.
69. Gilchrist DA, Fromm G, dos Santos G, Pham LN, McDaniel IE, Burkholder A, et al. Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks. Genes Dev (2012) 26:933-44. doi:10.1101/gad.187781.112.
70. Adelman K, Rogatsky I. RNA polymerase II stalling mediates cytokine gene expression. Cell Cycle (2010) 9:630-1. doi:10.4161/cc.9.4.10841.
71. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C, et al. Suppression of inflammation by a synthetic histone mimic. Nature (2010) 468:1119-23. doi:10.1038/nature09589.
72. Huang B, Yang X-D, Zhou M-M, Ozato K, Chen L-F. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol (2009) 29:1375-87. doi:10.1128/MCB.01365-08.
73. Garber M, Yosef N, Goren A, Raychowdhury R, Thielke A, Guttman M, et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol Cell (2012) 47:810-22. doi:10.1016/j.molcel.2012.07.030.
74. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 459:108-12. doi:10.1038/nature07829.
75. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature (2009) 457:854-8. doi:10.1038/nature07730.
76. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature (2011) 470:279-83. doi:10.1038/nature09692.
77. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, et al. Latent enhancers activated by stimulation in differentiated cells. Cell (2013) 152:157-71. doi:10.1016/j.cell.2012.12.018.
78. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature (2007) 447:972-8. doi:10.1038/nature05836.
79. Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, et al. Effect of natural genetic variation on enhancer selection and function. Nature (2013) 503:487-92. doi:10.1038/nature12615.